China-headquartered Lilly Asia Ventures has backed an $18 million seed extension round for US-based Rgenta Therapeutics. In a separate development, IntoCare Medical Technology (Suzhou) Co., Ltd has raked in nearly 100 million yuan ($15 million) in a Series D round of financing led by Qiming Venture Partners.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
